Implications of subclinical tuberculosis for vaccine trial design and global effect. (2024)
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1016/s2666-5247(24)00127-7
PubMed Identifier: 38964359
Publication URI: http://europepmc.org/abstract/MED/38964359
Type: Journal Article/Review
Volume: 5
Parent Publication: The Lancet. Microbe
Issue: 10
ISSN: 2666-5247